Viking Therapeutics (VKTX): Today’s Developments and Future Prospects

Viking Therapeutics (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on developing novel therapies for metabolic and endocrine disorders, has been in the spotlight today due to significant corporate developments and its recent financial performance. Today’s Key Developments On July 24,…